Current:Home > reviewsRobitussin cough syrup sold nationwide recalled due to contamination -MarketLink
Robitussin cough syrup sold nationwide recalled due to contamination
View
Date:2025-04-23 00:02:59
Haleon is recalling Robitussin cough syrup sold nationwide due to microbial contamination that could lead to deadly infections for at-risk people, the U.S.-based unit of the U.K.-based global consumer health company said on Wednesday.
Use of the recalled products could potentially result in severe or life-threatening fungal infections in those with impaired immune systems, Haleon stated in a notice posted by the Food and Drug Administration. Most users are unlikely to experience a serious health problem, but an infection that requiring medical intervention can't be ruled out, the company said.
Robitussin is widely used to relieve symptoms that come with cold, flu, hay fever or other respiratory allergies. The recall includes the following products, followed by their lot numbers and expiration dates:
- Robitussin Honey CF Max Day Adult 4oz — T10810 — October 31, 2025
- Robitussin Honey CF Max Day Adult 8oz — T08730, T08731, T08732, T08733 — May 31, 2025
- Robitussin Honey CF Max Day Adult 8oz — T10808 — September 30, 2025
- Robitussin Honey CF Max NT Adult 8oz — T08740, T08742 — June 30, 2026
Consumers who purchased the recalled products shouldn't use them, Haleon said. Customers with questions can call the company at (800) 245-1040 Monday through Friday, 8 a.m. to 6 p.m. Eastern time, or email mystory.us@haleon.com.
Kate GibsonKate Gibson is a reporter for CBS MoneyWatch in New York.
veryGood! (6)
Related
- Friday the 13th luck? 13 past Mega Millions jackpot wins in December. See top 10 lottery prizes
- For the first time in 15 years, liberals win control of the Wisconsin Supreme Court
- Flash Deal: Save 69% On the Total Gym All-in-One Fitness System
- What's next for the abortion pill mifepristone?
- Macy's says employee who allegedly hid $150 million in expenses had no major 'impact'
- Q&A: Plug-In Leader Discusses Ups and Downs of America’s E.V. Transformation
- Duracell With a Twist: Researchers Find Fix for Grid-Scale Battery Storage
- FDA pulls the only approved drug for preventing premature birth off the market
- Can Bill Belichick turn North Carolina into a winner? At 72, he's chasing one last high
- 1 dead, at least 18 injured after tornado hits central Mississippi town
Ranking
- The 401(k) millionaires club keeps growing. We'll tell you how to join.
- Biden Names Ocasio-Cortez, Kerry to Lead His Climate Task Force, Bridging Democrats’ Divide
- Don’t Miss This $65 Deal on $142 Worth of Peter Thomas Roth Anti-Aging Skincare Products
- This Week in Clean Economy: Wind Power Tax Credit Extension Splits GOP
- Behind on your annual reading goal? Books under 200 pages to read before 2024 ends
- Julian Sands' cause of death ruled 'undetermined' one month after remains were found
- Iam Tongi Wins American Idol Season 21
- Today's election could weaken conservatives' long-held advantage in Wisconsin
Recommendation
The Daily Money: Spending more on holiday travel?
Aerie's Clearance Section Has 76% Off Deals on Swimwear, Leggings, Tops & More
Pipeline Payday: How Builders Win Big, Whether More Gas Is Needed or Not
Transcript: Former Attorney General William Barr on Face the Nation, June 18, 2023
Can Bill Belichick turn North Carolina into a winner? At 72, he's chasing one last high
'You forget to eat': How Ozempic went from diabetes medicine to blockbuster diet drug
Man arrested after allegedly throwing phone at Bebe Rexha during concert
Q&A: Plug-In Leader Discusses Ups and Downs of America’s E.V. Transformation